Diligence memo · auto-generated · as of July 2, 2026
Pivot Bio, Inc.
Pivot Bio, Inc. has raised $623M over 5 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Pivot Bio, Inc. operates in Biotech / Pharma, based in Berkeley. Pivot Bio is dedicated to supporting farmers with products that optimize crop production through specific nitrogen delivery.
Capital & rounds (filed)filed
Pivot Bio, Inc. has raised $623M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Growth/Late (a round over $400M).
Largest single filing: $435M on 2021-06-28.
Most recent recorded round closed around 2021-06-28.
Valuation (modeled)modeled
Provath models Pivot Bio, Inc. at approximately $13.0B (range $2.8B–$21.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 16 months.
Last raise 5.0 yr ago; this sector typically re-raises about every 15 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 4.3× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 100% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 100% of those peers.
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.